ATH 33.3% 0.4¢ alterity therapeutics limited

Good to look at the reference study by Wenning et al, page-8

  1. 1,084 Posts.
    lightbulb Created with Sketch. 103
    Hi Pivalde,

    Great to see your still around.

    Cant wait to see these results, I will definately be ecstatic if we get 84.48% of applicants showing improvements.

    With the current sell of, this data cannot come quick enough to give a boost to the SP. Thankfully we have enough cash to get us through the last 2 quarters to see the end of the trials.

    Keep up the good work with your research papers, it keeps the us holders confident in this product and future for sufferers.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.